SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-134319
Filing Date
2024-05-08
Accepted
2024-05-08 17:00:57
Documents
13
Period of Report
2024-05-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d834255d8k.htm   iXBRL 8-K 26926
  Complete submission text file 0001193125-24-134319.txt   148834

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eigrq-20240503.xsd EX-101.SCH 2513
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigrq-20240503_lab.xml EX-101.LAB 17955
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigrq-20240503_pre.xml EX-101.PRE 11238
17 EXTRACTED XBRL INSTANCE DOCUMENT d834255d8k_htm.xml XML 3777
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 24927285
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)